James Wilbur's share sale prompts doubts about insiders’ vie...
James Wilbur's share sale prompts doubts about insiders’ view of stock's worth. No insider buying in past year may hint at uncertainty in company's future, despite high insider ownership suggesting management's awareness of shareholders' interests.
Chief Commercial Officer Of 10x Genomics Sold 87% Of Their Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment